Influence of bacterial presence on biofilm formation of Candida albicans

Yonsei Medical Journal

Volumn 55, Issue 2, 2014, Pages 449-458

  Park, Su Jung ^a   Han, Kyoung Hee ^a   Park, Joo Young ^a   Choi, Sun Ju ^a   Lee, Kyoung Ho ^a  

^a Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Bacteria; Biofilm; Candida albicans; Co culture

Indexed keywords

BACTERIA; BIOFILM; CANDIDA ALBICANS; CO-CULTURE;

ASPARTIC ACID ENDOPEPTIDASES; BIOFILMS; CANDIDA ALBICANS; COCULTURE TECHNIQUES; ESCHERICHIA COLI; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; HYPHAE; MEMBRANE GLYCOPROTEINS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES;

EID: 84894267652     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2014.55.2.449     Document Type: Article

References (28)

1. Samaranayake LP. Essential microbiology for dentistry. 3rd ed. New York: Churchill Livingstone Elsevier; 2006.
2. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annu Rev Med 2008;59:415-28.
3. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006;6:979-86.
4. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001;183:5385-94.
5. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol 2006;9:340-5.
6. Baillie GS, Douglas LJ. Role of dimorphism in the development of Candida albicans biofilms. J Med Microbiol 1999;48:671-9.
7. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004;17:255-67.
8. Hansen SK, Rainey PB, Haagensen JA, Molin S. Evolution of species interactions in a biofilm community. Nature 2007;445: 533-6.
9. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 2005;43: 5721-32.
10. Manson JM, Rauch M, Gilmore MS. The commensal microbiology of the gastrointestinal tract. Adv Exp Med Biol 2008;635:15-28.
11. Mclean RJC, Banes MB, McGowin CL, Aron GM. Methods of studying biofilms. In: Ghannoum MA, O'Toole GA, editors. Microbial biofilms. Washington, DC: ASM Press; 2004. p.379-413.
12. Tolker-Nielsen T, Hansen SK. Microbial interaction in mixed-species biofilms. In: Ghannoum MA, O'Toole GA, editors. Microbial biofilms. Washington, DC: ASM Press; 2004. p.206-21.
13. Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 2009;299:1-8.
14. Ramage G, Vandewalle K, Wickes BL, López-Ribot JL. Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 2001;18:163-70.
15. Thein ZM, Seneviratne CJ, Samaranayake YH, Samaranayake LP. Community lifestyle of Candida in mixed biofilms: a mini review. Mycoses 2009;52:467-75.
16. El-Azizi MA, Starks SE, Khardori N. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms. J Appl Microbiol 2004;96:1067-73.
17. Uppuluri P, Dinakaran H, Thomas DP, Chaturvedi AK, Lopez-Ribot JL. Characteristics of Candida albicans biofilms grown in a synthetic urine medium. J Clin Microbiol 2009;47:4078-83.
18. Nailis H, Kucharíková S, Ricicová M, Van Dijck P, Deforce D, Nelis H, et al. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression. BMC Microbiol 2010;10:114.
19. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005;28: 1062-8.
20. Li X, Yan Z, Xu J. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 2003;149(Pt 2):353-62.
21. Hogan DA, Kolter R. Pseudomonas-Candida interactions: an ecological role for virulence factors. Science 2002;296:2229-32.
22. Hogan DA, Vik A, Kolter R. A Pseudomonas aeruginosa quorumsensing molecule influences Candida albicans morphology. Mol Microbiol 2004;54:1212-23.
23. Bandara HM, Yau JY, Watt RM, Jin LJ, Samaranayake LP. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. J Med Microbiol 2009;58(Pt 12):1623-31.
24. Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 1999;283:1535-8.
25. Hoyer LL. The ALS gene family of Candida albicans. Trends Microbiol 2001;9:176-80.
26. Birse CE, Irwin MY, Fonzi WA, Sypherd PS. Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun 1993;61:3648-55.
27. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003;67:28-29.
28. Naglik JR, Challacombe SJ, Hube B. Candida albicans secretedmotility by Proteus mirabilis occurs in response to specific cues aspartyl proteinases in virulence and pathogenesis. Microbiol Molpresent in urine and requires excess L-glutamine. J Bacteriol Biol Rev 2013;195:1305-19.